Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2Sarcoma 1Lymphoid 1

Conditions

Osteosarcoma 6Lymphoma 4Renal Insufficiency 3Neoplasms 2Mucositis 2Lymphoma, Large B-Cell, Diffuse 2Leukemia 2Hematologic Neoplasms 2Drug-Related Side Effects and Adverse Reactions 2Water Intoxication 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neurotoxicity Syndromes 1Acute Kidney Injury 1

Interventions

Low-Level Light Therapy 5Radiation 4Radiotherapy 3Propolis 3Morphine 3Methotrexate 3Leucovorin 3Cryotherapy 3Cisplatin 3glucarpidase 2Probiotics 2Pentoxifylline 2Mouthwashes 2Melphalan 2Ketamine 2Interleukin 1 Receptor Antagonist Protein 2Honey 2Glutamine 2Gabapentin 2Fluorouracil 2Fibroblast Growth Factor 7 2Drug Therapy 2Amifostine 2peppermint oil 1pegfilgrastim 1pegaspargase 1oxycodone-acetaminophen 1nelarabine 1maltodextrin 1kang-lai-te 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Mucositis × glucarpidase × Clear all
NCT02022358 2015-06-04

Will Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays?

University College, London

Phase 2 Terminated
34 enrolled
OtherSarcoma

Osteosarcoma, Mucositis

NCT00727831 2014-01-27

Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

University College, London

Phase 1/2 Completed
4 enrolled
LymphoidOther

Lymphoma, Lymphoma, Large B-Cell, Diffuse, Neurotoxicity Syndromes, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡